NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000045714

Registered date:11/10/2021

Utility of DWI-MRI and histopathological evaluation on early response of HCC with molecular targeting therapy

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedHepatocellular carcinoma
Date of first enrollment2020/10/11
Target sample size50
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeRelationship between DWI-MRI, histopathologic evaluation, and exosome and radiological response on RECIST 1.1
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1. Allergy with iodine contrast media 2. eGFR is less than 40ml/min 3. Child-Pugh is B and C 4. Not suitable for the study due to researcher's decision

Related Information

Contact

public contact
Name Katsutoshi Sugimoto
Address 6-7-1, NIshi-shinjuku, Shinjuku-ku, Tokyo Japan 160-0023
Telephone 03-3342-6111
E-mail sugimoto@tokyo-med.ac.jp
Affiliation Tokyo Medical University Dept. of Gastroenterology and Hepatology
scientific contact
Name Katsutoshi Sugimoto
Address 6-7-1, NIshi-shinjuku, Shinjuku-ku, Tokyo Japan
Telephone 03-3342-6111
E-mail sugimoto@tokyo-med.ac.jp
Affiliation Tokyo Medical University Dept. of Gastroenterology and Hepatology